Nicox S.A. (ALCOX.PA)

EUR 0.23

(1.02%)

Operating Expenses Summary of Nicox S.A.

  • Nicox S.A.'s latest annual operating expenses in 2023 was -11.5 Million EUR , down -63.66% from previous year.
  • Nicox S.A.'s latest quarterly operating expenses in 2023 FY was 6 Million EUR , down -63.66% from previous quarter.
  • Nicox S.A. reported a annual operating expenses of 16.51 Million EUR in annual operating expenses 2022, down -34.99% from previous year.
  • Nicox S.A. reported a annual operating expenses of 25.39 Million EUR in annual operating expenses 2021, up 27.51% from previous year.
  • Nicox S.A. reported a quarterly operating expenses of 6 Million EUR for 2023 FY, down -63.66% from previous quarter.
  • Nicox S.A. reported a quarterly operating expenses of 1643.00 EUR for 2023 Q2, down 0.0% from previous quarter.

Annual Operating Expenses Chart of Nicox S.A. (2023 - 2019)

Historical Annual Operating Expenses of Nicox S.A. (2023 - 2019)

Year Operating Expenses Operating Expenses Growth
2023 -11.5 Million EUR -63.66%
2022 16.51 Million EUR -34.99%
2021 25.39 Million EUR 27.51%
2020 19.92 Million EUR 208.66%
2019 -18.33 Million EUR 0.0%

Peer Operating Expenses Comparison of Nicox S.A.

Name Operating Expenses Operating Expenses Difference
European Medical Solutions 13.64 Million EUR 184.29%
FERMENTALG 12.34 Million EUR 193.187%
argenx SE 1.34 Billion EUR 100.857%
BioSenic S.A. 7.58 Million EUR 251.695%
Celyad Oncology SA 8.49 Million EUR 235.489%
Hyloris Pharmaceuticals SA 17.98 Million EUR 163.952%
Onward Medical N.V. 20.64 Million EUR 155.718%
Oxurion NV 12.21 Million EUR 194.179%
PHAXIAM Therapeutics S.A. 24.98 Million EUR 146.038%
Financière de Tubize SA 114.38 Thousand EUR 10156.037%
UCB SA 2.94 Billion EUR 100.391%